vTv Therapeutics Inc. revenue breakdown overview

vTv Therapeutics Inc. revenue for the last year amounted to 1.02 M USD, the most of which — 1.02 M USD — came from its highest performing source at the moment, Orally Administered Small Molecule Drug, the year earlier bringing 2.02 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought vTv Therapeutics Inc. 1.02 M USD, and the year before that — 2.02 M USD.